Back to Results
First PageMeta Content
Tarenflurbil / Health / Placebo / Flurbiprofen / Non-steroidal anti-inflammatory drugs / Organofluorides / Medicine


Safety and Efficacy of Tarenflurbil in Subjects With Mild Alzheimer’s Disease: Results From an 18-month Multicenter Phase 3 Trial
Add to Reading List

Document Date: 2012-10-18 13:12:18

Open Document

File Size: 1,25 MB

Share Result on Facebook

Company

ADCS-ADL SA / ITT / /

Event

Product Issues / FDA Phase / Product Recall / /

IndustryTerm

treatment / /

MedicalCondition

Subjects With Mild Alzheimer’s Disease / Mild Alzheimer’s disease / /

Person

Andrew P. Beelen / Edward A. Swabb / Lon S. Schneider / David A. Amato / Kenton H. Zavitz / /

Product

subscale Mean / flurbiprofen / Population / /

Technology

800 mg BID n=506 Per Protocol Population Placebo n=502 Per Protocol / 3 Protocol / GSM / /

SocialTag